Determination of Drugs and Their Metabolites in Hospitalized Patients
NCT ID: NCT01702545
Last Updated: 2020-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2012-08-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This projects deals with the question of drug levels in the blood of hospitalized patients.
The aim of this study is to extend the knowledge about the behavior of drugs in the human body significantly, for the safety and benefit of future patients. This also includes to establish a relationship between drug levels in patients and the desired and undesired effects of a drug.
As a result, the future perspective is to find the optimal dose for the individual patient by measuring the blood concentration of a drug.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Food-effect Study on Uracil and Dihydrouracil Levels as a Diagnostic Marker of Dihydropyrimidine Dehydrogenase Activity
NCT02718664
Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury
NCT01000766
Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers
NCT01774994
Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics
NCT01845194
Pharmacokinetics of the Basel Phenotyping Cocktail Combination Capsule
NCT03247699
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
If the expectation is confirmed, that a significant heterogeneity in the plasma concentrations of these patients exists, the investigators will try to find influencing factors for this circumstance on the basis of routine clinical parameters (height, weight, renal function, concomitant medications, etc.).
Ultimately, this project will identify substances with a high interindividual variability in plasma levels, where drug monitoring might be suggested.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinikum Nürnberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mr. Prof. Dr. Wilhelm
Prof. Dr. med. Martin Wilhelm
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Wilhelm, Prof Dr.
Role: STUDY_CHAIR
Paracelsus Medical University Klinikum Nuremberg, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Internal Medicine V, Klinikum Nürnberg Nord
Nuremberg, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEAK-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.